Donglin Liu

发表

Systemic chemotherapy with or without hepatic arterial infusion chemotherapy for liver metastases from pancreatic cancer: a propensity score matching analysis

T. Si, Zhu-chen Yan, Ping Chen, 2022, Clinical Colorectal Cancer.

In-Vivo Fusion of Human Cancer and Hamster Stromal Cells Permanently Transduces and Transcribes Human DNA

D. Goldenberg, Chien-Hsing Chang, R. Rooney, 2014, PloS one.

Interferon-λ1 Linked to a Stabilized Dimer of Fab Potently Enhances both Antitumor and Antiviral Activities in Targeted Cells

D. Goldenberg, Thomas M. Cardillo, Thomas M Cardillo, 2013, PloS one.

Combination Therapy with Bispecific Antibodies and PD-1 Blockade Enhances the Antitumor Potency of T Cells.

Rongxiu Li, D. Goldenberg, Thomas M. Cardillo, 2017, Cancer research.

Combining ABCG2 Inhibitors with IMMU-132, an Anti–Trop-2 Antibody Conjugate of SN-38, Overcomes Resistance to SN-38 in Breast and Gastric Cancers

D. Goldenberg, Thomas M. Cardillo, Thomas M Cardillo, 2016, Molecular Cancer Therapeutics.

Trop-2-targeting tetrakis-ranpirnase has potent antitumor activity against triple-negative breast cancer

D. Goldenberg, Thomas M. Cardillo, Thomas M Cardillo, 2014, Molecular Cancer.

Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody-Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers.

D. Goldenberg, R. Sharkey, S. Govindan, 2015, Bioconjugate chemistry.

Predictive biomarkers for sacituzumab govitecan efficacy in Trop-2-expressing triple-negative breast cancer

D. Goldenberg, R. Sharkey, Thomas M Cardillo, 2020, Oncotarget.

Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin

D. Goldenberg, D. Gold, G. Newsome, 2013, Molecular Cancer.

Horizontal Transmission of Malignancy: In-Vivo Fusion of Human Lymphomas with Hamster Stroma Produces Tumors Retaining Human Genes and Lymphoid Pathology

E. Jaffe, D. Goldenberg, D. Gold, 2013, PloS one.

Identification of PAM4 (clivatuzumab)-reactive epitope on MUC5AC: A promising biomarker and therapeutic target for pancreatic cancer

D. Goldenberg, D. Gold, Donglin Liu, 2015, Oncotarget.

Mapping PAM4 (clivatuzumab), a monoclonal antibody in clinical trials for early detection and therapy of pancreatic ductal adenocarcinoma, to MUC5AC mucin

D. Goldenberg, D. Gold, G. Newsome, 2013, Molecular Cancer.

Core functional sequence of C-terminal GAG-binding domain directs cellular uptake of IGFBP-3-derived peptides.

P. Sinko, Xiaoping Zhang, Jieming Gao, 2013, Protein and peptide letters.

MYC overexpression but not MYC/BCL2 double expression predicts survival in bulky mass diffuse large B‐cell lymphoma patients

Xiao-yan Feng, Xudong Zhang, M. Dong, 2023, Cancer medicine.